These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24451612)

  • 1. A naturopathic approach to the prevention of cardiovascular disease: cost-effectiveness analysis of a pragmatic multi-worksite randomized clinical trial.
    Herman PM; Szczurko O; Cooley K; Seely D
    J Occup Environ Med; 2014 Feb; 56(2):171-6. PubMed ID: 24451612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturopathic medicine for the prevention of cardiovascular disease: a randomized clinical trial.
    Seely D; Szczurko O; Cooley K; Fritz H; Aberdour S; Herrington C; Herman P; Rouchotas P; Lescheid D; Bradley R; Gignac T; Bernhardt B; Zhou Q; Guyatt G
    CMAJ; 2013 Jun; 185(9):E409-16. PubMed ID: 23630244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of naturopathic care for chronic low back pain.
    Herman PM; Szczurko O; Cooley K; Mills EJ
    Altern Ther Health Med; 2008; 14(2):32-9. PubMed ID: 18383988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases: a randomized controlled trial.
    van Wier MF; Lakerveld J; Bot SD; Chinapaw MJ; Nijpels G; van Tulder MW
    BMC Fam Pract; 2013 Apr; 14():45. PubMed ID: 23557482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The (cost-)effectiveness of an individually tailored long-term worksite health promotion programme on physical activity and nutrition: design of a pragmatic cluster randomised controlled trial.
    Robroek SJ; Bredt FJ; Burdorf A
    BMC Public Health; 2007 Sep; 7():259. PubMed ID: 17888161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins?
    Grover SA; Ho V; Lavoie F; Coupal L; Zowall H; Pilote L
    Arch Intern Med; 2003 Feb; 163(3):333-9. PubMed ID: 12578514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease prevention and implications for worksite health promotion programs in Brazil.
    Cipriano G; Neves LM; Cipriano GF; Chiappa GR; Borghi-Silva A
    Prog Cardiovasc Dis; 2014; 56(5):493-500. PubMed ID: 24607013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 30-month worksite-based lifestyle program to promote cardiovascular health in middle-aged bank employees: Design of the TANSNIP-PESA randomized controlled trial.
    Coffeng JK; van der Ploeg HP; Castellano JM; Fernández-Alvira JM; Ibáñez B; García-Lunar I; van der Beek AJ; Fernández-Ortiz A; Mocoroa A; García-Leal L; Cárdenas E; Rojas C; Martínez-Castro MI; Santiago-Sacristán S; Fernández-Gallardo M; Mendiguren JM; Bansilal S; van Mechelen W; Fuster V
    Am Heart J; 2017 Feb; 184():121-132. PubMed ID: 28224926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study.
    Crossan C; Lord J; Ryan R; Nherera L; Marshall T
    Br J Gen Pract; 2017 Jan; 67(654):e67-e77. PubMed ID: 27821671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness and cost-benefit of a lifestyle intervention for workers in the construction industry at risk for cardiovascular disease.
    Groeneveld IF; van Wier MF; Proper KI; Bosmans JE; van Mechelen W; van der Beek AJ
    J Occup Environ Med; 2011 Jun; 53(6):610-7. PubMed ID: 21654430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle modification interventions and cardiovascular health: global perspectives on worksite health and wellness and cardiac rehabilitation.
    Arena R
    Prog Cardiovasc Dis; 2014; 56(5):473-5. PubMed ID: 24607010
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
    Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
    BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of worksite wellness intervention on cardiac risk factors and one-year health care costs.
    Milani RV; Lavie CJ
    Am J Cardiol; 2009 Nov; 104(10):1389-92. PubMed ID: 19892055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease.
    Hopkins RB; Garg AX; Levin A; Molzahn A; Rigatto C; Singer J; Soltys G; Soroka S; Parfrey PS; Barrett BJ; Goeree R
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1248-57. PubMed ID: 21617091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas.
    Wang H; Kenkel D; Graham ML; Paul LC; Folta SC; Nelson ME; Strogatz D; Seguin RA
    BMC Health Serv Res; 2019 May; 19(1):315. PubMed ID: 31096977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines.
    Pandya A; Weinstein MC; Salomon JA; Cutler D; Gaziano TA
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):25-32. PubMed ID: 24425701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computer-guided quality improvement tool for primary health care: cost-effectiveness analysis based on TORPEDO trial data.
    Patel B; Peiris DP; Patel A; Jan S; Harris MF; Usherwood T; Panaretto K; Lung T
    Med J Aust; 2020 Jul; 213(2):73-78. PubMed ID: 32594567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO/ISH total risk approach for primary prevention of cardiovascular disease shows greater decrease in costs for women but not the elderly in Jamaica.
    Abdulkadri AO; Tulloch-Reid MK; Francis DK; Gordon-Strachan GM; Younger-Coleman NO; Rocke KD; McFarlane SR; Cunningham-Myrie CA; Ferguson TS; Wilks RJ; Anderson SG
    J Clin Epidemiol; 2015 Sep; 68(9):994-1001. PubMed ID: 25819490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.
    Liu J; Mozaffarian D; Sy S; Lee Y; Wilde PE; Abrahams-Gessel S; Gaziano T; Micha R;
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006313. PubMed ID: 32493057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan.
    Tsutani K; Igarashi A; Fujikawa K; Evers T; Kubin M; Lamotte M; Annemans L
    Intern Med; 2007; 46(4):157-62. PubMed ID: 17301509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.